Multidisciplinary lymphedema treatment program

International Journal of Lower Extremity Wounds

Volumn 11, Issue 1, 2012, Pages 20-27

  Papadopoulou, Maria Christina ^a   Tsiouri, Ioanna ^a   Salta Stankova, Roumiana ^a   Drakou, Aikaterini ^a   Rousas, Nikolaos ^a   Roussaki Schulze, Aggeliki Victoria ^a   Giannoukas, Athanasios D ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

clinic; hospital; lymphedema; multidisciplinary; outpatient; program; unit

Indexed keywords

DIAGNOSTIC PROCEDURE; DIETITIAN; HEALTH PROGRAM; HIGH RISK POPULATION; HOME CARE; HUMAN; INTENSIVE CARE; LYMPHEDEMA; OUTPATIENT CARE; PHYSIOTHERAPIST; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PSYCHOLOGIST; QUALITY OF LIFE; REVIEW; SOCIAL WORKER; TREATMENT PLANNING;

HEALTH STATUS INDICATORS; HUMANS; LYMPHEDEMA; OUTPATIENTS; PATIENT CARE TEAM; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 84858980072     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734612438436     Document Type: Review

References (62)

1. Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96:731-738. (Pubitemid 37259362)
2. Gary DE. Lymphedema diagnosis and management. J Am Acad Nurse Pract. 2007;19:72-78.
3. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59:8-24.
4. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin. 2000;50:292-307.
5. Ryan M, Stainton MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol. 2003;43:148-151. (Pubitemid 36626120)
6. Regnard C, Allport S, Stephenson L. ABC of palliative care. Mouth care, skin care, and lymphoedema. BMJ. 1997;315:1002-1005. (Pubitemid 27443132)
7. MacLaren JA. Skin changes in lymphoedema: pathophysiology and management options. Int J Palliat Nurs. 2001;7:381-388.
8. Campisi C. Lymphoedema: modern diagnostic and therapeutic aspects. Int Angiol. 1999;18:14-24. (Pubitemid 29253664)
9. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer. 1998;83(12 suppl):2821-2827. (Pubitemid 29024274)
10. Cohen SR, Payne DK, Tunkel RS. Lymphedema strategies for management. Cancer. 1998;83(4 suppl):980-986.
11. Cheifetz O, Haley L; Breast Cancer Action. Management of secondary lymphedema related to breast cancer. Can Fam Physician. 2010;56:1277-1284.
12. Földi M, Földi E. Lymphoedema: Methods of Treatment and Control. New York, NY: Gustav Fischer Verlag; 1991.
13. Kasseroller RG. The Vodder school: the Vodder method. Cancer. 1998;83(12 suppl):2840-2842. (Pubitemid 29024278)
14. Casley-Smith JR, Boris M, Weindorf S, Lasinski B. Treatment for lymphedema of the arm - the Casley-Smith method: a noninvasive method produces continued reduction. Cancer. 1998;83(12 suppl):2843-2860. (Pubitemid 29024279)
15. Leduc O, Leduc A, Bourgeois P, Belgrado J-P. The physical treatment of upper limb edema. Cancer. 1998;83(12 suppl):2835-2839. (Pubitemid 29024277)
16. De Godoy JM, Batigalia F, Godoy Mde F. Preliminary evaluation of a new, more simplified physiotherapy technique for lymphatic drainage. Lymphology. 2002;35:91-93. (Pubitemid 34627665)
17. Granda C. Nursing management of patients with lymphedema associated with breast cancer therapy. Cancer Nurs. 1994;17:229-235. (Pubitemid 24163489)
18. Kirshbaum M. The development, implementation and evaluation of guidelines for the management of breast cancer related lymphoedema. Eur J Cancer Care (Engl). 1996;5:246-251. (Pubitemid 126672988)
19. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology. Lymphology. 2003;36:84-91.
20. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2009 consensus document of the International Society of Lymphology. Lymphology. 2009;42:51-60.
21. Lymphoedema Framework. Best Practice for the Managementof Lymphoedema: International Consesus. London, England: MEP; 2006.
22. Cormier G, Feldman J, Askew R, et al. ALFP to update the best practice document. J Lymphoedema.,2010;5:68-71.
23. Mirolo BR, Bunce IH, Chapman M, et al. Psychosocial benefits of postmastectomy lymphedema therapy. Cancer Nurs. 1995;18:197-205.
24. Matthews K, Smith J. Effectiveness of modified complex physical therapy for lymphoedema treatment. Aust J Physiother. 1996;42:323-328. (Pubitemid 27023107)
25. Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J. 2004;10:42-48. (Pubitemid 44313573)
26. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol. 2007;14:1904-1908. (Pubitemid 46870933)
27. Koul R, Dufan T, Russell C, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys. 2007;67:841-846. (Pubitemid 46223526)
28. Yamamoto R, Yamamoto T. Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol. 2007;12:463-468. (Pubitemid 350243845)
29. Didem K, Ufuk YS, Serdar S, Zümre A. The comparison of two different physiotherapy methods in treatment of lymphedema after breast surgery. Breast Cancer Res Treat. 2005;93:49-54. (Pubitemid 41355990)
30. Karadibak D, Yavuzsen T, Saydam S. Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema. J Surg Oncol. 2008;97:572-577. (Pubitemid 351794145)
31. Araújo JA, Curbelo JG, Mayol AL, Pascal GG, Vignale RA, Fleurquin F. Effective management of marked lymphedema of the leg. Int J Dermatol. 1997;36:389-392. (Pubitemid 27278510)
32. Holtgrefe KM. Twice-weekly complete decongestive physical therapy in the management of secondary lymphedema of the lower extremities. Phys Ther. 2006;86:1128-1136. (Pubitemid 44148064)
33. Megens A, Harris SR. Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther. 1998;78:1302-1311. (Pubitemid 28565308)
34. Lerner R. Complete decongestive physiotherapy and the Lerner Lymphedema Services Academy of Lymphatic Studies (the Lerner school). Cancer. 1998;83 (12 suppl):2861-2863. (Pubitemid 29024280)
35. Arrault M, Vignes S. Management of lymphedema of the upper extremity after treatment of breast Cancer. Bull Cancer. 2007;94:669-674. (Pubitemid 47413889)
36. Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer-related lymphedema. Mayo Clin Proc. 2005;80:1480-1484. (Pubitemid 41567225)
37. Ridner SH, Dietrich MS, Kidd N. Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer. 2011;19:631-637.
38. Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer. 1998;83(12 suppl):2817-2820. (Pubitemid 29024273)
39. Tobin M, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Cancer. 1993;72:3248-3252.
40. Passik SD, Newman M, Brennan M, Tunkel R. Predictors of psychological distress, sexual dysfunction and physical functioning among women with upper extremity lymphedema related to breast cancer. Psychooncology. 1995;4:255-263. (Pubitemid 26094146)
41. Brennan MJ. Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage. 1992;7:110-116.
42. Woods M. A hospital-based service for lymphoedema management. Eur J Cancer Care (Engl). 1993;2:165-168.
43. Vignes S, Champagne A, Poisson O. Management of lymphedema: experience of the Cognacq-Jay hospital [in French]. Rev Med Interne. 2002;23(suppl 3):414s-420s.
44. Evrard-Bras M, Coupé M, Quéré I, Janbon C. Physical therapy of lymphedema: Montpellier's experience [in French]. Rev Med Interne. 2002;23(suppl 3):408s-413s.
45. Strauss-Blasche G, Gnad E, Ekmekcioglu C, Hladschik B, Marktl W. Combined inpatient rehabilitation and spa therapy for breast cancer patients: effects on quality of life and CA 15-3. Cancer Nurs. 2005;28:390-398. (Pubitemid 41395660)
46. Williams AE, Bergl S, Twycross RG. A 5-year review of a lymphoedema service. Eur J Cancer Care (Engl). 1996;5:56-59. (Pubitemid 126672920)
47. Bunce IH, Mirolo BR, Hennessy JM, Ward LC, Jones LC. Post-mastectomy lymphoedema treatment and measurement. Med J Aust. 1994;161:125-128.
48. Gerber LH. American Cancer Society Lymphedema Workshop. A review of measures of lymphedema. Cancer. 1998;83(12 suppl):2803-2804.
49. Tewari N, Gill PG, Bochner MA, Kollias J. Comparison of volume displacement versus circumferential arm measurements for lymphoedema: implications for the SNAC trial. ANZ J Surg. 2008;78:889-893.
50. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999;177:184-187.
51. Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of earlystage breast cancer. Arch Surg. 2002;137:1253-1257. (Pubitemid 35345897)
52. Taira N, Shimozuma K, Shiroiwa T, et al. Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery. Breast Cancer Res Treat. 2011;128:735-747.
53. Symvoulakis EK, Anyfantakis DI, Lionis C. Primary lower limb lymphedema: a focus on its functional, social and emotional impact. Int J Med Sci. 2010;7:353-357.
54. Cheville AL, Almoza M, Courmier JN, Basford JR. A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema. Cancer. 2010;116:3722-3731.
55. Augustin M, Bross F, Foldi E, Vanscheidt W, Zschocke I. Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema. Vasa. 2005;34:31-35. (Pubitemid 40321813)
56. Runowicz CD, Passik SD, Hann D, et al. American Cancer Society Lymphedema Workshop. Workgroup II: patient education - pre- and posttreatment. Cancer. 1998;83(12 suppl):2880-2881.
57. Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res. 2009;301:561-571.
58. Blome C, Augustin M, Behechtnejad J, Rustenbach SJ. Dimensions of patient needs in dermatology: subscales of the patient benefit index. Arch Dermatol Res. 2011;303:11-17.
59. Vignes S, Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol. 2007;46:1138-1142. (Pubitemid 350058880)
60. Vignes S, Porcher R, Arrault M, Dupuy A. Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer. 92011;19:935-940.
61. Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396. doi: 10.1136/bmj.b5396.
62. Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75:51-64.